asenapine / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
asenapine / Generic mfg.
open label asenapine high risk psychosi, ChiCTR-ONRC-14005047: A Prospective Open-Label Treatment Trial of Asenapine Monotherapy in subjects at Clinical High Risk for Psychosis

Completed
N/A
119
 
asenapine
secretaria de ciencia y tecnica UNR; community mental health center Ramon Carrilllo, none
psychosis
 
 
NCT01734278: Observational Post-Authorisation Safety Study of Asenapine (Sycrest)

Completed
N/A
1000
Europe
No intervention
Professor Saad Shakir, Merck Sharp & Dohme LLC
Manic Disorder
01/17
01/18
NCT01765127: An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)

Completed
N/A
122
Europe
Professor Saad Shakir, Merck Sharp & Dohme LLC
Bipolar I Disorder
02/17
01/18
NCT01495741: Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307)

Completed
N/A
42
NA
Organon and Co
Bipolar Disorder, Schizophrenia
12/17
12/17
NCT01498770: An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)

Completed
N/A
42
NA
Asenapine, Sycrest, SCH 900274, Aripiprazole, Abilfy, Quetiapine, Seroquel, Risperidone, Risperdal, Olanzapine, Zyprexa, Ziprasidone, Iloperidone, Paliperidone, Lurasidone, Clozapine, Amisulpride, Sertindole, Zotepine
Organon and Co
Bipolar Disorder
12/17
12/17
FIRST, NCT02600741: Family Intervention in Recent Onset Schizophrenia Treatment

Completed
N/A
296
US
Caregiver psycho-education and skills training, Caregiver support available at the study site, Paliperidone palmitate, Chlorpromazine, Droperidol, Fluphenazine, Haloperidol, Loxapine, Perphenazine, Pimozide, Prochlorperazine, Thiothixene, Thioridazine, Trifluoperazine, Aripiprazole, Asenapine, Clozapine, Iloperidone, Olanzapine, Paliperidone, Quetiapine, Risperidone, Ziprasidone
Janssen Scientific Affairs, LLC
Schizophrenia
07/18
07/18
NCT02893371: Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

Terminated
N/A
1037352
US
Lithium Carbonate, Lithobid, Lamotrigine, Lamictal, Valproic Acid, Depakote, Valproate, Oxcarbazepine, Trileptal, Carbamazepine, Equetro, Ziprasidone, Geodon, Risperidone, Risperdal, Quetiapine, Seroquel, Olanzapine, Zyprexa, Aripiprazole, Abilify, Fluoxetine / Olanzapine, Symbyax, Haloperidol, Haldol Decanoate, Perphenazine, Trilafon, Clozapine, Clozaril, Asenapine, Saphris, Lurasidone, Latuda, Paliperidone, Invega, Mirtazapine, Remeron, Remeronsoltab, Bupropion, Zyban, Aplenzin, Wellbutrin, Desvenlafaxine, Pristiq, Desfax, Duloxetine, Cymbalta, Irenka, Venlafaxine, Effexor XR, Citalopram, Celexa, Escitalopram, Lexapro, Fluoxetine, Prozac, Sarafem, Fluvoxamine, Faverin, Fevarin, Floxyfral, Dumyrox, Luvox, Paroxetine, Paxil, Seroxat, Sertraline, Zoloft, Vilazodone, Viibryd, Doxepin, Sinequan, Silenor
University of New Mexico, Patient-Centered Outcomes Research Institute, Montana State University, National Alliance on Mental Illness Montana, CGStat LLC, Risk Benefit Statistics LLC, National Alliance on Mental Illness New Mexico, National Alliance on Mental Illness Westside Los Angeles
Bipolar Disorder
06/19
06/19

Download Options